Role of the ACE ID and PPARG P12A polymorphisms in genetic susceptibility of diabetic nephropathy in a South Indian population

Nephro-Urology Monthly

Volumn 5, Issue 3, 2013, Pages 813-817

  Bhaskar, Lakkakula V K S ^a   Mahin, Sultana ^a   Ginila, Raju Thankabai ^a   Soundararajan, Periyasamy ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Alleles; Angiotensin converting enzyme 2; Diabetic nephropathies; PPAR Gamma

Indexed keywords

ALANINE; DIPEPTIDYL CARBOXYPEPTIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE;

ACE GENE; ALLELE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA ISOLATION; ELECTROPHORESIS; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PPARG GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 84887841258     PISSN: 22517006     EISSN: 22517014     Source Type: Journal    
DOI: 10.5812/numonthly.9573     Document Type: Article

References (36)

1. Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care. 2006;29(2):334-9.
2. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983;25(6):496-501.
3. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989;320(18):1161-5.
4. Teare MD. Candidate gene association studies. Methods Mol Biol. 2011;713:105-17.
5. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343-6.
6. Bhavani AB, Sastry KB, Reddy NK, Padma T. Lipid profile and apolipoprotein E polymorphism in essential hypertension. Indian Heart J. 2005;57(2):151-7.
7. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J. 1993;290 (Pt 1):33-40.
8. Li AC, Glass CK. PPAR-and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J Lipid Res. 2004;45(12):2161-73.
9. Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefebvre AM, Saladin R, et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem. 1997;272(30):18779-89.
10. Greene ME, Blumberg B, McBride OW, Yi HF, Kronquist K, Kwan K, et al. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr. 1995;4(4-5):281-99.
11. Salem AH, Batzer MA. High frequency of the D allele of the angiotensin-converting enzyme gene in Arabic populations. BMC Res Notes. 2009;2:99.
12. Stumvoll M, Haring H. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes. 2002;51(8):2341-7.
13. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl. 1993;3(2):120-1.
14. Cubells JF, Kobayashi K, Nagatsu T, Kidd KK, Kidd JR, Calafell F, et al. Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am J Med Genet. 1997;74(4):374-9.
15. Jeffers BW, Estacio RO, Raynolds MV, Schrier RW. Angiotensinconverting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int. 1997;52(2):473-7.
16. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int. 1996;50(2):657-64.
17. Kunz R, Bork JP, Fritsche L, Ringel J, Sharma AM. Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. J Am Soc Nephrol. 1998;9(9):1653-63.
18. Kazemi B, Seyed N, Moslemi E, Bandehpour M, Bikhof Torbati M, Saadat N, et al. Insulin receptor gene mutations in iranian patients with type II diabetes mellitus. Iran Biomed J. 2009;13(3):161-8.
19. Grzeszczak W, Zychma MJ, Lacka B, Zukowska-Szczechowska E. Angiotensin I-converting enzyme gene polymorphisms: relationship to nephropathy in patients with non-insulin dependent diabetes mellitus. J Am Soc Nephrol. 1998;9(9):1664-9.
20. Schmidt S, Schone N, Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int. 1995;47(4):1176-81.
21. Prasad P, Tiwari AK, Kumar KM, Ammini AC, Gupta A, Gupta R, et al. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Med Genet. 2006;7:42.
22. Viswanathan V, Zhu Y, Bala K, Dunn S, Snehalatha C, Ramachandran A, et al. Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. JOP. 2001;2(2):83-7.
23. Ng DP, Tai BC, Koh D, Tan KW, Chia KS. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia. 2005;48(5):1008-16.
24. Das KJ, Sharma P, Naswa N, Soundararajan R, Kumar R, Bal C, et al. Hybrid SPECT-CT with 99mTc-labeled red blood cell in a case of blue rubber bleb nevus syndrome: added value over planar scintigraphy. Diagn Interv Radiol. 2012;19(1):41-3.
25. Li LL, Ma XL, Ran JX, Sun XF, Xu LM, Ren J, et al. Genetic polymorphism of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala on ethnic susceptibility to diabetes in Uygur, Kazak and Han subjects. Clin Exp Pharmacol Physiol. 2008;35(2):187-91.
26. Sale MM, Smith SG, Mychaleckyj JC, Keene KL, Langefeld CD, Leak TS, et al. Variants of the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in an African-American population enriched for nephropathy. Diabetes. 2007;56(10):2638-42.
27. Erdogan M, Karadeniz M, Eroglu Z, Tezcanli B, Selvi N, Yilmaz C. The relationship of the peroxisome proliferator-activated receptor-gamma 2 exon 2 and exon 6 gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy. Diabetes Res Clin Pract. 2007;78(3):355-9.
28. Caramori ML, Canani LH, Costa LA, Gross JL. The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes. Diabetes. 2003;52(12):3010-3.
29. Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E. Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro-12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study. Diabetes. 2002;51(8):2653-7.
30. Pollex RL, Mamakeesick M, Zinman B, Harris SB, Hegele RA, Hanley AJ. Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes. J Diabetes Complications. 2007;21(3):166-71.
31. Kalita J, Somarajan BI, Kumar B, Mittal B, Misra UK. A study of ACE and ADD1 polymorphism in ischemic and hemorrhagic stroke. Clin Chim Acta. 2011;412(7-8):642-6.
32. Pasha MA, Khan AP, Kumar R, Ram RB, Grover SK, Srivastava KK, et al. Variations in angiotensin-converting enzyme gene insertion/ deletion polymorphism in Indian populations of different ethnic origins. J Biosci. 2002;27(1 Suppl 1):67-70.
33. Saha N, Talmud PJ, Tay JS, Humphries SE, Basair J. Lack of association of angiotensin-converting enzyme (ACE). Gene insertion/ deletion polymorphism with CAD in two Asian populations. Clin Genet. 1996;50(3):121-5.
34. Bhagat N, Agrawal M, Luthra K, Vikram NK, Misra A, Gupta R. Evaluation of single nucleotide polymorphisms of Pro12Ala in peroxisome proliferator-activated receptor-gamma and Gly308Ala in tumor necrosis factor-alpha genes in obese Asian Indians: a population-based study. Diabetes Metab Syndr Obes. 2010;3:349-56.
35. Radha V, Vimaleswaran KS, Babu HN, Abate N, Chandalia M, Satija P, et al. Role of genetic polymorphism peroxisome proliferatoractivated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity. Diabetes Care. 2006;29(5):1046-51.
36. Tai ES, Corella D, Deurenberg-Yap M, Adiconis X, Chew SK, Tan CE, et al. Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population. J Lipid Res. 2004;45(4):674-85.